Moberg Pharma: Interview with CEO Anna Ljung (video)

Research Interview



We have invited Anna Ljung, CEO of Moberg Pharma, to comment on the interim report and the phase 3 clinical trial.


Gergana Almquist

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.